BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Friday, April 19, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
April 7, 2015
View Archived Issues
SSA-37A: a neuroprotective agent that could modulate AD progression
Read More
BLZ-100: a Tumor Paint candidate for imaging skin cancer
Read More
Pyrazolopiperidines from Janssen show activity as brain-penetrant P2X7 receptor antagonists
Read More
Basilea Pharmaceutica in-licenses pan-RAF kinase inhibitors
Read More
Pfizer presents novel irreversible EGFR T790M inhibitors
Read More
Research reveals new roles for known biomarkers
Read More
NCI and Intrexon to collaborate on T-cell therapies for cancer
Read More
VLP Therapeutics enters dengue vaccine collaboration with Nagasaki University
Read More
Roche describes new neurogenesis modulators
Read More
Aurigene discloses PD-1 signaling inhibitors
Read More
Identification of novel spiro-hydantoins as SARMs
Read More
Humira approved in Europe to treat children with severe plaque psoriasis
Read More
Bayer Schering Pharma patents CCR2 antagonists
Read More
Compugen discloses VSTM5 polypeptides
Read More
U.S. investigators develop modified L-asparaginases
Read More
Natpara now available in the U.S.
Read More
Lilly agrees to supply pemetrexed for phase II trial of demcizumab in NSCLC
Read More
Novel sensor shows potential for blood ammonia management
Read More
Enzalutamide extends survival compared with bicalutamide in castration-resistant prostate cancer
Read More
U.K. Medical Research Council and UCB partner to discover monoclonal antibodies
Read More
Curis' CUDC-907 receives FDA orphan drug designation for DLBCL
Read More
FDA grants fast track status to Perosphere's anticoagulant antidote PER-977
Read More
EMA approves Vectibix for metastatic colorectal cancer expressing wild-type RAS
Read More
Rucaparib given breakthrough therapy designation for BRCA-mutated ovarian cancer
Read More
Supplemental NDA filed for Pradaxa for the setting of hip replacement surgery
Read More
BMS and uniQure team up to develop gene therapies for cardiovascular disease
Read More
Alkermes reports on phase II trial of olanzapine/samidorphan combination in schizophrenia
Read More
Celldex Therapeutics starts phase I/II trial of varlilumab and ipilimumab in melanoma
Read More